UK Medicines Information
Revised SPC: IntronA (interferon alfa-2b) preparations
Information type:
Drug prescribing
Source:
electronic Medicines compendium
Specialities:
Cardiovascular system disorders | Infection and infectious diseases | Liver disorders
Summary
SPC warns that cases of hepatitis B re-activation have been reported in patients co-infected with hepatitis B and C viruses treated with interferon, and advises that all patients be screened for hepatitis B before starting treatment. Pericarditis has been added as a side-effect.
UKMi comment
The same updates have also been made to other interferon products (e.g. ViraferonPeg).
Related links: